Blood Biomarker of Alzheimer's Disease (AD)

  • STATUS
    Recruiting
  • participants needed
    60
  • sponsor
    Duke University
Updated on 20 September 2024
cancer
alzheimer's disease
blood test
memory disorders
Accepts healthy volunteers

Summary

Currently, no cures or disease modifying therapies exist for Alzheimer's disease (AD). This is partially due to the inability to detect the disease before it has progressed to a stage where there are clinical manifestations. The identification and validation of high throughput biomarkers to measure disease progression (as well as identify pre-clinical disease onset) is critical to the development of disease-modifying or even preventative therapies. In this study, we are testing a blood biomarker for stratification of Alzheimer's disease patients and healthy volunteers. This study may lead to future blood tests that may help earlier diagnosis of Alzheimer's disease and detect the disease progression.

Details
Condition Alzheimer's Disease
Age 50years - 100years
Clinical Study IdentifierNCT03340571
SponsorDuke University
Last Modified on20 September 2024

Eligibility

Yes No Not Sure

Inclusion Criteria

Alzheimer's Disease Patients
years and older
AD patient who is seen at the Memory Disorders Clinic
AD diagnosis
Non smoking
No cancer treatment in the last 5 years
Informed consent from the patient or the patient's legally authorized representative (LAR)
Patient and/or LAR able to read and speak English
Healthy Control Participants
years and older
Non smoking
No cancer treatment in the last 5 years
Age matched to AD subject
Able to read and speak English

Exclusion Criteria

Alzheimer's Disease Patients
Known additional neurological disease
Healthy Control Participants
Neurological degenerative diseases (such as Parkinson's, Alzheimer's or Huntington's)
Clear my responses

How to participate?

Step 1 Connect with a study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.